(Q79812038)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315168%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Therapeutic radiation for lymphoma: risk of malignant mesothelioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315168%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

M Jane Teta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315168%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Edmund Lau

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315168%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Bonnielin K Sceurman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315168%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Meghan E Wagner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315168%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315168%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315168%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315168%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315168%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

1432-1438

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315168%20AND%20SRC:MED&resulttype=core&format=json

Risk of second cancers after treatment for Hodgkin's disease

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Leukemia following Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Second cancers following non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Risk of leukemia following treatment for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Evolving role of radiation therapy for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Combined chemotherapy plus radiotherapy for treatment of early-stage intermediate- and high-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Management of Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Breast cancer after treatment of Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Re: Lung cancer risk and radiation dose among women treated for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Radiation-induced peritoneal mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Malignant peritoneal mesothelioma following radiotherapy for seminoma of the testis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Malignant pleural mesothelioma following radiotherapy in a 16-year-old boy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Pleural malignant mesothelioma following Wilms' tumor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Further evidence of nonasbestos-related mesothelioma. A review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Malignant mesothelioma of the pleura: review of 123 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Colon cancers and peritoneal mesothelioma occurring 29 years after abdominal radiation for testicular seminoma. A case report and review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Malignant peritoneal mesothelioma associated with deep vein thrombosis following radiotherapy for seminoma of the testis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Radiation associated malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Malignant mesothelioma following radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Post-irradiation malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Malignant mesothelioma following treatment for Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Post-irradiation malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Long term survival of a patient with malignant pleural mesothelioma as a late complication of radiotherapy for Hodgkin's disease treated with 90yttrium-silicate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Deciduoid mesothelioma of the pleura after radiation therapy for Hodgkin's disease presenting as a mediastinal mass

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Incidence of malignant pleural mesothelioma after thoracic radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

A systematic overview of radiation therapy effects in Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Therapy-associated solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22526

7 January 2021

Identifiers

DOI

10.1002/CNCR.22526

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315168%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference